Your browser doesn't support javascript.
loading
Primary Evan Syndrome With Disseminated Intravascular Coagulation Suggests Progressive Immune Dysregulation and Early Immunosuppressive Intervention is Key to Improving Outcomes.
Siddiqui, Nauman; Toumeh, Anis; Yoon, Yongsook; Verghese, Cherian.
Afiliação
  • Siddiqui N; 1Department of Medicine, University of Toledo Medical Center, Toledo, OH; and 2Division of Hematology and Oncology, Department of Pathology, University of Toledo Medical Center, Toledo, OH.
Am J Ther ; 23(4): e1105-7, 2016.
Article em En | MEDLINE | ID: mdl-25415543
ABSTRACT
Evan syndrome (ES) is a rare hematological disorder that involves 2 or more immune cytopenias. It usually includes autoimmune hemolytic anemia and autoimmune thrombocytopenia. Although occasionally associated with immune neutropenia, its association with disseminated intravascular coagulation (DIC) is rare. And, early diagnosis with appropriate intervention is important because mortality from ES is known to be greater than that of isolated immune hemolytic anemia and probably worse in the presence of DIC. Considering that the presence of DIC can make the diagnosis of ES challenging, a strong clinical suspicion is important as early initiation of therapy is critical to reducing the morbidity and mortality associated with this syndrome. We report a case of ES complicated by DIC.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Coagulação Intravascular Disseminada / Anemia Hemolítica Autoimune Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Coagulação Intravascular Disseminada / Anemia Hemolítica Autoimune Idioma: En Ano de publicação: 2016 Tipo de documento: Article